help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suh, D.-S.
Right arrow Articles by Rechler, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suh, D.-S.
Right arrow Articles by Rechler, M. M.
Molecular Endocrinology 11 (12): 1822-1831
Copyright © 1997 by The Endocrine Society

Hepatocyte Nuclear Factor 1 and the Glucocorticoid Receptor Synergistically Activate Transcription of the Rat Insulin-like Growth Factor Binding Protein-1 Gene

Dae-Shik Suh and Matthew M. Rechler

Growth and Development Section Molecular and Cellular Endocrinology Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20892

The insulin-like growth factor (IGF) binding proteins (IGFBPs) are a family of proteins that bind IGF-I and IGF-II and modulate their biological activities. IGFBP-1 is distinctive among the IGFBPs in its rapid regulation in response to metabolic and hormonal changes. The synthetic glucocorticoid, dexamethasone, increases IGFBP-1 mRNA abundance and gene transcription in rat liver and in H4-II-E rat hepatoma cells. A glucocorticoid response element (GRE) located at nucleotide (nt) -91/-77 is required for dexamethasone to stimulate rat IGFBP-1 promoter activity in transient transfection assays in H4-II-E cells. In addition to the GRE, three accessory regulatory sites [a putative hepatocyte nuclear factor-1 (HNF-1) site (nt -62/-50), an insulin-response element (nt -108/-99), and an upstream site (nt -252/-236)] are involved in dexamethasone stimulation under some, but not all, circumstances. The present study begins to address the mechanism by which transcription factors bound to the putative HNF-1 site act synergistically with the glucocorticoid receptor (GR) bound to the GRE. In gel shift assays, HNF-1{alpha} and HNF-1ß in H4-II-E extracts bind to the palindromic HNF-1 site. Both half-sites are required. Overexpression of HNF-1ß enhances dexamethasone-stimulated promoter activity. Both the HNF-1 site and the GRE must be intact for stimulation to occur. By contrast, overexpression of HNF-1{alpha} does not enhance dexamethasone-stimulated promoter activity, although, as also observed with overexpression of HNF-1ß, it inhibits basal promoter activity. Thus, the synergistic effects of HNF-1ß and the GR on dexamethasone-stimulated promoter activity require that they are bound to the HNF-1 site and the GRE, respectively, and may involve protein-protein interactions between the transcription factors, or between them and the basal transcription machinery or a steroid receptor coactivator. Synergy between the ubiquitously expressed GR and HNF-1, which is developmentally regulated and expressed in a limited number of tissues, provides a possible mechanism for tissue- and development-specific regulation of glucocorticoid action.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
Y.-B. Xie, B. Nedumaran, and H.-S. Choi
Molecular characterization of SMILE as a novel corepressor of nuclear receptors
Nucleic Acids Res., July 1, 2009; 37(12): 4100 - 4115.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
H. Nogami, Y. Hiraoka, K. Ogasawara, S. Aiso, and S. Hisano
The role of pit-1 in the regulation of the rat growth hormone-releasing hormone receptor gene transcription by glucocorticoids
J. Mol. Endocrinol., December 1, 2005; 35(3): 477 - 488.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. T. Vander Kooi, H. Onuma, J. K. Oeser, C. A. Svitek, S. R. Allen, C. W. Vander Kooi, W. J. Chazin, and R. M. O'Brien
The Glucose-6-Phosphatase Catalytic Subunit Gene Promoter Contains Both Positive and Negative Glucocorticoid Response Elements
Mol. Endocrinol., December 1, 2005; 19(12): 3001 - 3022.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-G. Scharf, T. G. Unterman, and T. Kietzmann
Oxygen-Dependent Modulation of Insulin-Like Growth Factor Binding Protein Biosynthesis in Primary Cultures of Rat Hepatocytes
Endocrinology, December 1, 2005; 146(12): 5433 - 5443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Jiang, M. Norman, L. Roth, and X. Li
Protein-DNA Array-based Identification of Transcription Factor Activities Regulated by Interaction with the Glucocorticoid Receptor
J. Biol. Chem., September 10, 2004; 279(37): 38480 - 38485.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-S. Kwon, B. Huang, T. G. Unterman, and R. A. Harris
Protein Kinase B-{alpha} Inhibits Human Pyruvate Dehydrogenase Kinase-4 Gene Induction by Dexamethasone Through Inactivation of FOXO Transcription Factors
Diabetes, April 1, 2004; 53(4): 899 - 910.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. J Playford, C. E Macdonald, and W. S Johnson
Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders
Am. J. Clinical Nutrition, July 1, 2000; 72(1): 5 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Streeper, C. A. Svitek, J. K. Goldman, and R. M. O'Brien
Differential Role of Hepatocyte Nuclear Factor-1 in the Regulation of Glucose-6-phosphatase Catalytic Subunit Gene Transcription by cAMP in Liver- and Kidney-derived Cell Lines
J. Biol. Chem., April 14, 2000; 275(16): 12108 - 12118.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. I. McKay and J. A. Cidlowski
Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways
Endocr. Rev., August 1, 1999; 20(4): 435 - 459.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Kim, R. C. Jaffe, and A. T. Fazleabas
Insulin-Like Growth Factor Binding Protein-1 Expression in Baboon Endometrial Stromal Cells: Regulation by Filamentous Actin and Requirement for de Novo Protein Synthesis
Endocrinology, February 1, 1999; 140(2): 997 - 1004.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. S. Song, M. H. Jung, S. C. Kim, T. Hassan, A. K. Roy, and B. Chatterjee
Tissue-specific and Androgen-repressible Regulation of the Rat Dehydroepiandrosterone Sulfotransferase Gene Promoter
J. Biol. Chem., August 21, 1998; 273(34): 21856 - 21866.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. S. Streeper, E. M. Eaton, D. H. Ebert, S. C. Chapman, C. A. Svitek, and R. M. O'Brien
Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription
PNAS, August 4, 1998; 95(16): 9208 - 9213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society